Dyadic to Webcast Upcoming Investor Presentations
April 10 2006 - 7:00AM
Business Wire
Dyadic International, Inc. (AMEX: DIL), a biotechnology company,
announced today that Mark Emalfarb, CEO and Glenn Nedwin, Ph.D.,
Chief Scientific Officer and President of Dyadic's Biosciences
Business, will make the following presentations to the financial
community: -- on Tuesday, April 11, 2006 at approximately 1:15 p.m.
EDT in Chicago and -- on Tuesday, April 18, 2006 at approximately
7:45 a.m. EDT in New York. Mr. Emalfarb and Dr. Nedwin will review
Dyadic's C1 Host Technology development program, the company's
cellulosic ethanol opportunity, as well as its progress in
industrial enzymes and the advancement of C1 Expression Technology
for use in the development and production of antibodies and other
therapeutic proteins. Both presentations will be webcast live and
can be accessed at http://www.dyadic-group.com. An archive of the
webcasts will be available for approximately 30 days. Prior to
joining Dyadic in March 2006, Dr. Nedwin was co-founder and
President of Novozymes, Inc., a research & development
subsidiary of Novozymes A/S, Denmark (Copenhagen Stock Exchange:
NZYMb.CO). About Dyadic Dyadic International, Inc. is engaged in
the development, manufacture and sale of biological products using
a number of proprietary fungal strains to produce enzymes and other
biomaterials, principally focused on a system for protein
production based on the patented Chrysosporium lucknowense fungus,
known as C1. Dyadic currently sells more than 45 liquid and dry
enzyme products to more than 200 industrial customers in
approximately 50 countries. Dyadic intends to utilize its patented
enabling and proprietary platform technologies on its own behalf
and under license to business collaborators for the discovery,
development and manufacture of biological products from genes to
produce targeted protein products for diverse markets. Cautionary
Statement for Forward-Looking Statements Certain statements
contained in this press release are "forward-looking statements."
These forward-looking statements involve risks and uncertainties
that could cause our actual results, performance or achievements to
be materially different from any future results, performance or
achievements expressed or implied by such forward-looking
statements. For a discussion of these risks and uncertainties,
please see our filings from time to time with the Securities and
Exchange Commission, which are available free of charge on the
SEC's web site at http://www.sec.gov, including our Annual Report
on Form 10-KSB for the year ended December 31, 2005. Except as
required by law, we expressly disclaim any intent or obligation to
update any forward-looking statements.
Dyadic (AMEX:DIL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Dyadic (AMEX:DIL)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Dyadic International (American Stock Exchange): 0 recent articles
More Dyadic International, Inc. News Articles